[{"NetIncomeLoss_1_Q1_USD":33413000.0,"OperatingLeaseLiability_0_Q1_USD":3486000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":10.48,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":8486000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":308000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-91000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":70905000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":61610000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":107725000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":435000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":64000.0,"AssetsCurrent_0_Q1_USD":264009000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":11970000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":93000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":1177600.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":110000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":539000.0,"UnrecognizedTaxBenefits_0_Q1_USS":0.0,"CommonStockSharesIssued_0_Q1_shares":43548419.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":697000.0,"Assets_0_Q1_USD":274916000.0,"Liabilities_0_Q1_USD":22699000.0,"ShareBasedCompensation_1_Q1_USD":4698000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1515000.0,"OtherAssetsNoncurrent_0_Q1_USD":4833000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":21579000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":22.64,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":3817000.0,"EarningsPerShareBasic_1_Q1_USD":0.8,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":53000.0,"InventoryWriteDown_1_Q1_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":44383791.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-338000.0,"AccountsReceivableNetCurrent_0_Q1_USD":5997000.0,"CommonStockValue_0_Q1_USD":4000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":-2993000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":130000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-435000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":107835000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q1_USD":4698000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q1_USD":0.0,"CostsAndExpenses_1_Q1_USD":33642000.0,"OtherAssetsCurrent_0_Q1_USD":4736000.0,"IncreaseDecreaseInInventories_1_Q1_USD":1005000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":33413000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":33848000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-2829000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":252271000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":1543000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":3979000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"EarningsPerShareDiluted_1_Q1_USD":0.75,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":33413000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":435000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-31861000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":41870759.0,"ResidualValueOfLeasedAsset_0_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":1587000.0,"LiabilitiesCurrent_0_Q1_USD":17000000.0,"AccountsPayableCurrent_0_Q1_USD":6543000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":252271000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":110000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":995000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.076,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":33413000.0,"AdditionalPaidInCapital_0_Q1_USD":504091000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":46000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"OperatingLeasePayments_1_Q1_USD":544000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":60000.0,"DividendsCommonStock_1_Q1_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":64628000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2095000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":5997000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":39.08,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":137637000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-251787000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":107725000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":331000.0,"ProceedsFromSaleOfProductiveAssets_1_Q1_USD":62010000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"OperatingIncomeLoss_1_Q1_USD":-28259000.0,"InventoryNet_0_Q1_USD":1005000.0,"PreferredStockValue_0_Q1_USD":null,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1_Q1_USD":62010000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":2.4,"OperatingLeaseCost_1_Q1_USD":646000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":274916000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":26000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1971000.0,"ProfitLoss_1_Q1_USD":33413000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1934000.0,"StockholdersEquity_0_Q1_USD":252217000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":400000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":5602100.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":3189667.0,"CurrentIncomeTaxExpenseBenefit_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1627000.0,"Ticker":"YMAB","CIK":"1722964","name":"Y-MABS THERAPEUTICS, INC.","OfficialName":"Y-mAbs Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"556910423.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]